Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05434650 · ClinicalTrials.gov registry record

Abbott Atrial Fibrillation Post Approval Study

A clinical trial of Atrial Arrhythmia and Atrial Tachycardia, sponsored by Abbott Medical Devices.

Active
Registry status
200
Enrollment target
20
Study locations

NCT05434650 is a study of Atrial Arrhythmia and Atrial Tachycardia that is active but no longer recruiting, run by Abbott Medical Devices. The registered enrollment target is 200 participants, below the 235-participant average among 4 other Atrial Arrhythmia trials with a reported enrollment target (15% lower). The trial reports 20 study locations across 16 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05434650, a study of Atrial Arrhythmia and Atrial Tachycardia, is active but no longer recruiting, sponsored by Abbott Medical Devices.

ACTIVE NOT RECRUITING
Registry status
200 participants
Enrollment target
20
Study locations

Study Summary

This post-approval study is designed to provide continued real-world clinical evidence to confirm the safety and long-term effectiveness of atrial fibrillation (AF) radiofrequency (RF) technologies (e.g. TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ (TactiCath SE)) for the treatment of AF.

Conditions Studied

Atrial Arrhythmia Atrial Tachycardia Atrium; Fibrillation

Interventions

  • DEVICE electrophysiology study and ablation with an Abbott Ablation Catheter

Study Locations (20)

California

  • Eisenhower Medical Center - Rancho Mirage
  • Sequoia Hospital - Redwood City

Massachusetts

  • Brigham & Women's Hospital - Boston
  • Beth Israel Deaconess Medical Center - Boston

Tennessee

  • Erlanger Medical Center - Chattanooga
  • Centennial Medical Center - Nashville

Virginia

  • Sentara Norfolk General Hospital - Norfolk
  • Chippenham Hospital - Richmond

Alabama

  • Heart Center Research, LLC. - Huntsville

Arkansas

  • Arkansas Cardiology - Little Rock

Georgia

  • Northside Hospital - Atlanta

Louisiana

  • Ochsner Medical Center - New Orleans

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2022-10-21
Est. Completion 2026-11-30

Sponsor

Abbott Medical Devices

261 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05434650

The ClinicalTrials.gov registry entry for NCT05434650 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 235-participant average among 4 other Atrial Arrhythmia trials with a reported enrollment target (15% lower). The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Atrial Arrhythmia appearing as the primary indexed condition, and to 1 intervention - of which electrophysiology study and ablation with an Abbott Ablation Catheter is the first listed.

NCT05434650 reports 20 study locations spanning 16 distinct geographic areas - top geographies include California, Massachusetts, Tennessee.

Frequently Asked Questions

What is clinical trial NCT05434650 about?

NCT05434650 is a clinical study titled "Abbott Atrial Fibrillation Post Approval Study". This post-approval study is designed to provide continued real-world clinical evidence to confirm the safety and long-term effectiveness of atrial fibrillation (AF) radiofrequency (RF) technologies (e.g. TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ (TactiCath SE)) for the treatment of...

What is the current status of trial NCT05434650?

This trial is currently active not recruiting. The enrollment target is 200 participants. The study started on 2022-10-21. Estimated completion is 2026-11-30.

What conditions does trial NCT05434650 study?

This clinical trial studies the following conditions: Atrial Arrhythmia, Atrial Tachycardia, Atrium; Fibrillation.

What interventions are being tested in trial NCT05434650?

The interventions under investigation include: electrophysiology study and ablation with an Abbott Ablation Catheter (DEVICE).

Who is sponsoring clinical trial NCT05434650?

This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05434650 being conducted?

This trial has 20 study locations across Alabama, Arkansas, California, Georgia, Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Atrial Arrhythmia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Atrial Arrhythmia

All registered trials for this condition

Atrial Tachycardia

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.